We are live on ! Find out more
BLU

BELLUS Health Inc.

Delisted

BLU was delisted on the 28th of June, 2023.

46 hedge funds and large institutions have $137M invested in BELLUS Health Inc. in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more capital invested

Capital invested by funds: $52.8M → $137M (+$84.6M)

86% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 7

8% less funds holding

Funds holding: 5046 (-4)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

Holders
46
Holders Change
-4
Holders Change %
-8%
% of All Funds
0.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
13
Reduced
7
Closed
19
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$19M +$16.9M +6,220,058 New
APM
2
Avidity Partners Management
Texas
$17.5M +$15.5M +5,726,000 New
RI
3
RTW Investments
New York
$15.8M +$2.69M +994,506 +24%
AG
4
Artal Group
Luxembourg
$14.5M +$11.6M +4,275,000 +900%
O
5
OrbiMed
New York
$12.6M -$2.57M -947,623 -18%
PCH
6
Polar Capital Holdings
United Kingdom
$10.7M +$9.48M +3,500,000 New
BC
7
Boxer Capital
California
$9.1M
Janus Henderson Group
8
Janus Henderson Group
United Kingdom
$5.63M +$5.03M +1,856,737 New
SAM
9
Sectoral Asset Management
Quebec, Canada
$5.19M +$4.6M +1,696,940 New
ACM
10
Altium Capital Management
New York
$5.15M +$4.56M +1,682,535 New
SCM
11
Suvretta Capital Management
New York
$4.71M +$3.52M +1,300,000 +540%
FM
12
Frazier Management
Washington
$3.9M
MWNA
13
Marshall Wace North America
New York
$3.63M +$1.52M +562,500 +90%
Citadel Advisors
14
Citadel Advisors
Florida
$3.53M +$558K +205,974 +22%
Arrowstreet Capital
15
Arrowstreet Capital
Massachusetts
$1.51M +$474K +175,098 +55%
AIC
16
AWM Investment Company
New York
$1.22M +$1.08M +400,000 New
Morgan Stanley
17
Morgan Stanley
New York
$826K -$2.53M -934,769 -78%
JG
18
Jefferies Group
New York
$413K +$366K +135,091 New
IC
19
Ikarian Capital
Texas
$306K
LCM
20
Laurion Capital Management
New York
$306K +$271K +100,000 New
Bank of Montreal
21
Bank of Montreal
Ontario, Canada
$256K +$159K +58,620 +398%
FWSM
22
First Wilshire Securities Management
California
$251K
Millennium Management
23
Millennium Management
New York
$211K +$187K +68,847 New
Renaissance Technologies
24
Renaissance Technologies
New York
$173K +$153K +56,400 New
Deutsche Bank
25
Deutsche Bank
Germany
$138K -$93.6K -34,550 -43%

BLU Hedge Fund Activity: Q4 2020 in Review

46 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q4 2020, worth a combined $137M — up 160% from $52.8M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of BLU and 16 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 13 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $16.9M. The largest seller was OrbiMed, cutting an estimated $2.57M.

  • 46 institutional investors held BELLUS Health Inc. (BLU) as of Q4 2020, down from 50 in Q3 2020.
  • Funds reported $137M of BELLUS Health Inc. stock for Q4 2020, up 160% quarter-over-quarter.
  • 16 funds opened new BELLUS Health Inc. positions in Q4 2020 and 19 closed out, a net change of -3 holders.
  • The largest BELLUS Health Inc. buyer in Q4 2020 was Point72 Asset Management, an estimated $16.9M added.
  • The largest BELLUS Health Inc. seller in Q4 2020 was OrbiMed, an estimated $2.57M sold.

Based on aggregated 13F filings for Q4 2020.